Current status and recommendations for biomarkers and biobanking in neurofibromatosis

Authors

C. Oliver Hanemann, Peninsula Medical School
Jaishri O. Blakeley, Johns Hopkins University
Fabio P. Nunes, Eli Lilly
Kent Robertson, Indiana University-Purdue University Indianapolis
Anat Stemmer-Rachamimov, Harvard University
Victor Mautner, University of Hamburg
Andreas Kurtz, Charité Universitätsmedizin Berlin
Michael Ferguson, Indiana University-Purdue University Indianapolis
Brigitte C. Widemann, National Institutes of Health
D. Gareth Evans, University of Manchester
Rosalie Ferner, Guy's and St Thomas' NHS Foundation Trust
Steven L. Carroll, Medical University of South Carolina
Bruce Korf, University of Alabama at Birmingham
Pierre Wolkenstein, GHU Henri Mondor
Pamela Knight, Children's Tumor Foundation (CTF)
Scott R. Plotkin, Harvard University

ORCID

• C. Oliver Hanemann: 0000-0002-1951-1025

DOI Link

10.1212/WNL.0000000000002932

DOI

10.1212/WNL.0000000000002932

Publication Date

2016-08-16

Publication Title

Neurology

Volume

87

ISSN

0028-3878

First Page

40

Last Page

48

Recommended Citation

Hanemann, C., Blakeley, J., Nunes, F., Robertson, K., Stemmer-Rachamimov, A., Mautner, V., Kurtz, A., Ferguson, M., Widemann, B., Evans, D., Ferner, R., Carroll, S., Korf, B., Wolkenstein, P., Knight, P., & Plotkin, S. (2016) 'Current status and recommendations for biomarkers and biobanking in neurofibromatosis', Neurology, 87, pp. 40-48. Available at: 10.1212/WNL.0000000000002932